Featured Research

from universities, journals, and other organizations

High rates of drug-resistant TB among UK prisoners

Date:
April 5, 2010
Source:
BMJ-British Medical Journal
Summary:
UK prisoners are significantly more likely to have drug-resistant TB than other people with the disease, suggests new research.

UK prisoners are significantly more likely to have drug resistant TB than other people with the disease, suggests research published ahead of print in the Journal of Epidemiology and Community Health.

And one in four of TB cases fall through the healthcare net once they leave prison.

The researchers profiled the features of newly diagnosed adult cases reported to the national TB surveillance service for England and Wales between 2004 and 2007.

During this period, 29,340 cases of TB disease were reported, of which 205 were prison inmates.

An overseas birth is a known risk factor for TB. But prisoners with TB were almost twice as likely to be born in the UK rather than overseas -- 47% vs 25% -- compared with other TB patients.

And they were nine times more likely to be of black Caribbean ethnicity -- 18% vs 2%. Three out of four also had TB disease in their lungs, compared with just over half (56%) of other TB patients.

Prisoners with TB in their lungs were significantly more likely to be infectious -- 69% vs 57%.

Rates of drug resistant disease were also extremely high among prisoners. More than one in three (35%) had a strain of TB that was resistant to the drug normally prescribed as treatment -- isoniazid.

This means that a minimum 4% of all drug resistant cases occurred in prisoners during this period, say the researchers, and among drug resistant cases born in the UK, 11% were known to be prisoners (25 out of 228 cases).

Prisoners also fare worse than other TB patients, the study shows: fewer than half completed their treatment within a year -- 48% vs 80%.

And one in four of those still receiving treatment when they left prison fell through the healthcare net and did not get further check-ups. More than half of them (55%) had the drug resistant form of TB.

Compared with other TB patients, fewer prisoners died before they completed their treatment, but their average age at death was significantly lower -- 48 compared with 70.

The authors warn that their figures are likely to underestimate the true prevalence of TB disease among UK prisoners as the study did not include former prisoners or those with latent/unreported infection.

"High rates of [TB], especially drug-resistant tuberculosis, among prisoners with low levels of successful treatment mean prisoners present a particular challenge for tuberculosis control," they say.

The authors acknowledge that moves are afoot to strengthen control of the disease in UK prisons, but they point out that prisoners are particularly vulnerable as their health is often already compromised by drug and alcohol problems, homelessness, and HIV infection.


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. Anderson et al. Tuberculosis in UK prisoners: a challenge for control. Journal of Epidemiology & Community Health, 2010; 64 (4): 373 DOI: 10.1136/jech.2009.094375

Cite This Page:

BMJ-British Medical Journal. "High rates of drug-resistant TB among UK prisoners." ScienceDaily. ScienceDaily, 5 April 2010. <www.sciencedaily.com/releases/2010/03/100316112458.htm>.
BMJ-British Medical Journal. (2010, April 5). High rates of drug-resistant TB among UK prisoners. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/03/100316112458.htm
BMJ-British Medical Journal. "High rates of drug-resistant TB among UK prisoners." ScienceDaily. www.sciencedaily.com/releases/2010/03/100316112458.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins